GGrantIndex
← Search

University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)

$115,000P30FY2022CANIH

University Of Southern California, Los Angeles CA

Investigators

Linked publications, trials & patents

Trial NCT07456436Trial NCT07339254Trial NCT07332312Trial NCT07312162Trial NCT07306338Trial NCT07279571Trial NCT07276048Trial NCT07259304Trial NCT07229443Trial NCT07186699Trial NCT07162194Trial NCT07082257Trial NCT07076147Trial NCT06500169Trial NCT06422455Trial NCT06420219Trial NCT06374251Trial NCT06338657Trial NCT06336928Trial NCT06336902Trial NCT06297265Trial NCT06191575Trial NCT06171607Trial NCT06132087Trial NCT06128525Trial NCT06067295Trial NCT06063928Trial NCT06063486Trial NCT06060873Trial NCT05989828Trial NCT05791448Trial NCT05786664Trial NCT05516485Trial NCT05514990Trial NCT05462561Trial NCT05340309Trial NCT04981834Trial NCT04941430Trial NCT04927559Trial NCT04832763Trial NCT04830735Trial NCT04752267Trial NCT04387084Trial NCT04387071Trial NCT04373044Trial NCT04318028Trial NCT04315701Trial NCT04162678Trial NCT03971266Trial NCT03921047Trial NCT03858205Trial NCT03789773Trial NCT03739801Trial NCT03698162Trial NCT03657641Trial NCT03594448Trial NCT03576963Trial NCT03568292Trial NCT03568266Trial NCT03563651Trial NCT03563352Trial NCT03552796Trial NCT03537690Trial NCT03519984Trial NCT03514927Trial NCT03492801Trial NCT03485794Trial NCT03412370Trial NCT03408561Trial NCT03353896Trial NCT03348137Trial NCT03344211Trial NCT03330821Trial NCT03300609Trial NCT03300401Trial NCT03284346Trial NCT03267680Trial NCT03257761Trial NCT03238664Trial NCT03234556Trial NCT03207854Trial NCT03176979Trial NCT03146871Trial NCT03137706Trial NCT03120390Trial NCT03111823Trial NCT03098277Trial NCT03092856Trial NCT03091842Trial NCT03091816Trial NCT03091803Trial NCT03057639Trial NCT03049618Trial NCT03042897Trial NCT02978846Trial NCT02970617Trial NCT02970045Trial NCT02968680Trial NCT02967380Trial NCT02960308

Abstract

PROJECT SUMMARY – Overall Component The USC Norris Comprehensive Cancer Center at the University of Southern California (NCCC) has been continuously funded as an NCI-designated Comprehensive Cancer Center since 1973. NCCC has a rich tradition of collaborative research and serves as a major regional and international resource for cancer research, education, community outreach and engagement, and patient-centered oncology care. Our vision is to reduce the burden of cancer for all people. A central priority for NCCC is to serve the unique cancer-related needs of our multicultural catchment area, Los Angeles County (LAC). To achieve this goal, our 187 full members form collaborative teams and are organized into five impactful Research Programs served by six valuable Shared Resources (SRs). NCCC’s Cancer Research Training and Education Coordination (CRTEC) programs are part of the fabric of these efforts, creating a diverse pipeline for the next generation of exceptional cancer scientists and clinicians. The NCCC Office of Community Outreach and Engagement (COE) is the primary vehicle by which we understand, engage, and serve the needs of the underserved communities in our catchment area. Our geographic location in the 4th most diverse city in the nation affords opportunities for NCCC to lead in research that addresses cancer burdens and disparities among diverse communities and special populations. Indeed, NCCC is distinguished by exceptional success in recruiting diverse populations to clinical trials, with minorities accounting for more than 61% of interventional therapeutic accruals. This application requests: 1) support for five interactive Research Programs; 2) partial support for six SRs and one Developing Preclinical SR that provide technologies, services, and scientific consultation that will enhance member interaction and productivity; 3) support for Leadership, Planning, and Evaluation; 4) support for Developmental Funds to foster pursuit of new priorities, strengthen science, and explore new collaborations and technologies, all aligned with the new NCCC Strategic Plan; 5) support for Cancer Center Administration; and 6) support centralized scientific oversight of cancer clinical trials. Members currently hold grants totaling $101.3M (direct costs) with $37.7M from NCI and have authored landmark publications representing high intra-programmatic (26%), inter-programmatic (25%) and multi-institutional (45%) cancer research. Continued funding from the Cancer Center Support Grant (CCSG) will allow us to build on our strengths in basic, population, and clinical sciences, and to facilitate discovery and its translation into direct benefit to patients and diverse communities.

View original record on NIH RePORTER →